Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer [Phase 2]
Open-label Phase II trial of AZD4635 in prostate cancer, including metastatic castration-resistant disease; trial completed with results pos…
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease [Phase 3]
A Phase 3 trial comparing cardiovascular safety of degarelix versus leuprolide in advanced prostate cancer patients with cardiovascular dise…
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer [Phase 2]
Phase 2 trial comparing immediate prostatectomy to cabozantinib followed by prostatectomy in high-risk non-metastatic prostate cancer was te…
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) [Phase 2]
Phase 2 clinical trial assessing supraphysiologic testosterone to resensitize prostate cancer and overcome resistance; study completed with …
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. [Phase 2]
Phase 2 clinical trial exploring fecal microbiota transplant in combination with pembrolizumab for metastatic castration-resistant prostate …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Postoperative Pain, Recovery and Discharge Following Robot-assisted Laparoscopic Prostatectomy [Phase 3]
Phase 3 clinical trial update on postoperative pain, recovery, and discharge after robot-assisted laparoscopic prostatectomy has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating apalutamide with leuprolide in intermediate and high-risk prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma [Phase 2]
Phase 2 trial update for men with metastatic prostatic adenocarcinoma has completed.
-
FDA approval · 2022-06-16FDA Approved: GALLIUM GA-68 PSMA-11 — Supplemental Application (UCLA Biomedical Cyclotron)
The FDA approved a supplemental application for Gallium-68 PSMA-11 (Gallium-68 Gozetotide) from UCLA Biomedical Cyclotron, updating its regu…
-
FDA approval · 2022-06-16FDA Approved: GALLIUM GA-68 PSMA-11 — Supplemental Application (UCSF Radiopharmaceutical Facility)
The FDA approved a supplemental application for Gallium-68 PSMA-11 (Gozetotide) from the UCSF Radiopharmaceutical Facility.
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating hydroxychloroquine in patients with rising PSA after local therapy for prostate cancer has complete…
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase 2 trial comparing 177Lu-PSMA617 theranostic therapy to cabazitaxel in progressive metastatic castration-resistant prostate cancer has …
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study [Phase 4]
Phase 4 clinical trial update on volatile anesthesia and perioperative outcomes in cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Prostate Cancer Detection Screening MRI Protocol [NA]
Clinical trial update for a prostate cancer detection screening MRI protocol; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer [Phase 3]
Phase 3 trial comparing hypofractionated versus conventional radiation therapy after prostate cancer surgery; study completed with results p…
-
FDA approval · 2022-06-06FDA Approved: LEUPROLIDE ACETATE — Original Application (Eugia US LLC)
The FDA approved Eugia US LLC's generic Leuprolide Acetate under an Original Application (ANDA 212963), making a generic version of this med…
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 study of durvalumab and tremelimumab in chemotherapy-naive metastatic castration-resistant prostate cancer has completed; results we…
-
FDA approval · 2022-05-19FDA Approved: ABIRATERONE ACETATE — Supplemental Application (NORTHSTAR RX LLC)
FDA approved a supplemental application for Abiraterone acetate from Northstar RX LLC, resulting in approval of a generic product under ANDA…
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery [Phase 1, Phase 2]
Clinical trial update evaluating radiotherapy plus hormone therapy in biochemically-relapsing prostate adenocarcinoma after radical prostate…
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 trial evaluating the combination of testosterone and olaparib in castration-resistant prostate cancer has completed, with results …
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer [NA]
Phase II prospective study evaluating MRI reclassification for men considering active surveillance in prostate cancer; study completed with …
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Efavirenz in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial investigating efavirenz for metastatic prostate cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating isatuximab plus cemiplimab in advanced malignancies (prostate cancer and non-small cell lung cancer) has terminat…
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel [Phase 3]
Phase 3 trial evaluating two cabazitaxel dosing schedules in elderly men with metastatic prostate cancer previously treated with docetaxel h…
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers [Phase 2]
Phase 2 clinical trial update evaluating monitoring of metastatic prostate cancer using [18F]DCFPyL PET imaging and blood-based biomarkers.